IL-1β and IL-18: inflammatory markers or mediators of hypertension?
about
Novel adaptive and innate immunity targets in hypertension.Immune Mechanisms in Arterial Hypertension.Influence of interleukin-1 beta gene polymorphisms on the risk of myocardial infarction and ischemic stroke at young age in vivo and in vitro.Inflammasome activity is essential for one kidney/deoxycorticosterone acetate/salt-induced hypertension in mice.Relation between Arterial Stiffness and Markers of Inflammation and Hemostasis - Data from the Population-based Gutenberg Health Study.Increased adipose tissue expression of IL-18R and its ligand IL-18 associates with inflammation and insulin resistance in obesity.Red cell DAMPs and inflammation.Inflammasome Activation in Chronic Glomerular Diseases.Toll-like receptor 4 mediates vascular remodeling in hyperhomocysteinemia.IL-1β Inhibition in Cardiovascular Complications Associated to Diabetes Mellitus.Pressor response to angiotensin II is enhanced in aged mice and associated with inflammation, vasoconstriction and oxidative stress.Melatonin antagonizes interleukin-18-mediated inhibition on neural stem cell proliferation and differentiationRole of NLRP3 inflammasome in the pathogenesis of cardiovascular diseases.NLRP3 inflammasome activation contributes to VSMC phenotypic transformation and proliferation in hypertension.MicroRNA-365 alleviates morphine analgesic tolerance via the inactivation of the ERK/CREB signaling pathway by negatively targeting β-arrestin2.NLRP3 inflammasome activation regulated by NF-κB and DAPK contributed to paraquat-induced acute kidney injury.DNA Methylation and Histone Modification in Hypertension.Increased IL18 mRNA levels in peripheral artery disease and its association with triglyceride and LDL cholesterol levels: a pilot study.Increased Expression of Interleukin-18 mRNA is Associated with Carotid Artery StenosisThe beneficial effects of Lactobacillus reuteri ADR-1 or ADR-3 consumption on type 2 diabetes mellitus: a randomized, double-blinded, placebo-controlled trial
P2860
Q30235116-1A3D61BD-A5F7-4E0C-B3D9-1E69D5BD290EQ35759577-3BCF1A45-CBC1-40C6-AB1E-2EE8DF44CF80Q36464263-D69CB802-21EA-4D89-9F4B-25F9931BDA10Q36546979-08A764AC-E9B3-4253-8D66-6BDC23E83DFFQ38652417-7D8CA086-46E2-4863-AC96-80E4DAC8EF7CQ38784122-084EFE0C-664D-4AF4-8B7E-7269FBE5FA5DQ38850672-827E2B9F-C7D8-478B-929B-250AC1D721E0Q38931056-D811232F-7D44-4CE8-92AA-84D3E395EC56Q39225879-3EE2DD12-8307-445C-9CE6-1A638779AD28Q39403443-2F9592DE-7E9A-434D-9334-35388117234EQ41008506-1B1E6A3A-519E-4005-8ED2-E459155DA1A0Q41520482-6286FAD5-200A-4DE8-807A-4458CDF193ACQ47682969-C5E09E70-5C38-44D8-B4E1-95916FB956DEQ48239109-C7A018CE-3904-473B-B539-8D375A024577Q49354156-FDE2C429-7C5C-4477-B6B4-4259F8DBEE12Q51131939-51B45912-C73E-4F8B-9239-52164A52516FQ52591890-C16936B2-C387-408B-AEED-FDE5EBB95D62Q53326416-6F00AB3F-1582-49D2-AD46-41281B651FDFQ55232584-DA1FDD7A-73A9-4D96-9956-8F3617BC0411Q59127001-17D9EFB8-91C2-465E-B956-9FF4277C83E8
P2860
IL-1β and IL-18: inflammatory markers or mediators of hypertension?
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
IL-1β and IL-18: inflammatory markers or mediators of hypertension?
@ast
IL-1β and IL-18: inflammatory markers or mediators of hypertension?
@en
IL-1β and IL-18: inflammatory markers or mediators of hypertension?
@nl
type
label
IL-1β and IL-18: inflammatory markers or mediators of hypertension?
@ast
IL-1β and IL-18: inflammatory markers or mediators of hypertension?
@en
IL-1β and IL-18: inflammatory markers or mediators of hypertension?
@nl
prefLabel
IL-1β and IL-18: inflammatory markers or mediators of hypertension?
@ast
IL-1β and IL-18: inflammatory markers or mediators of hypertension?
@en
IL-1β and IL-18: inflammatory markers or mediators of hypertension?
@nl
P2093
P2860
P356
P1476
IL-1β and IL-18: inflammatory markers or mediators of hypertension?
@en
P2093
P2860
P304
P356
10.1111/BPH.12876
P407
P5008
P577
2014-12-01T00:00:00Z